Threshold Pharma (THLD) to conduct a 1:11 reverse split; renames itself Molecular Templates (MTEM)

    

  

A month later:

Eric Poma, Ph.D. Chief Executive Officer & Chief Science Officer, rings the Nasdaq Closing Bell on Sept 1, 2017. 

The reverse stock split will become effective at 5:00 p.m. EDT on August 1, 2017. Subject to the satisfaction of customary closing conditions, the closing of the merger with Molecular Templates is expected to occur shortly following the effectiveness of the reverse stock split.

• Additionally, an equity financing in the amount of $40 million is expected to close following the closing of the merger with Molecular Templates, and a separate $20 million equity investment is expected to close following the $40 million financing.
• Assuming the closing of the merger occurs as expected, the shares of common stock for the combined company, which will be renamed Molecular Templates, Inc., will commence trading on The NASDAQ Stock Market on a post-reverse stock split basis under the new symbol "MTEM" on August 2, 2017.